We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 87.860.0%Oct 23 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: erickerickson9/13/2019 8:59:12 AM
2 Recommendations

Recommended By

  Read Replies (1) of 59236
People don't learn. There was a message after we added another buck on Wednesday about how that was good. And you awakened the "Gris Gris". Shame shame shame! ;)

I try to not get excited about moves either up or down at this point, we're waiting for

1> resubmission
2> approval

Pretty much everything else is noise.

Just to contradict myself though, I do find it interesting that IMMU didn't slack off after the CRL, they continued full steam ahead. I'm sure they may have trimmed back on some new expenditures, and maybe left some positions open that they would have filled if there were no CRL. And sure, good news for UC will be welcome (and any other study results of course). It's just that until the CRL issues are fixed (and the FDA agrees), I'm not going to get giddy...

Imagine the CRL if Dr. G. were still in charge and we had only had a few months operating expenses in the bank.....

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext